Bristol-Myers Squibb initiates phase I trial of BMS-986235 in healthy subjects Nov. 24, 2017 No Comments
First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104 Nov. 15, 2017 No Comments
University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors Oct. 19, 2017 No Comments
RSS